This study enrolls adults with Relapsing Multiple Sclerosis. The purpose of this study is to learn about changes in cognition that happen while being treated with the experimental medication RPC1063 (also known as ozanimod). Read More
- Adults ages 18-65.
- Have at least 5 years since time of RMS diagnosis.
- Have no clinically relevant cardiovascular conditions.
Participants with or without multiple sclerosis are needed for this research study on audio-visual cognition. Participants will be asked to complete some short questionnaires and cognitive tasks over the span of approximately 2-3 hours. All testing will be completed in one session at the University at Buffalo's Division of Cognitive and Behavioral Neurosciences Laboratories. Read More
-Age range 20-65 years
-Normal Hearing and Vision
-DO NOT have the following: severe psychiatric disorder, alcohol or substance abuse or dependence, history of traumatic head injury, neurological disturbances other than multiple sclerosis.
Participants will be asked questions about a new cognitive processing test (how fast they can think). This study involves a single visit which takes about 20-minutes at the Conventus Medical Center in Buffalo. 50 multiple sclerosis patients and 50 healthy people will be enrolled. Read More
Physician established diagnosis of multiple sclerosis
18 years of age or older
Able to read and speak English
This study enrolls people with Multiple Sclerosis who have already enrolled in the New York State Multiple Sclerosis Consortium (NYSMSC). The purpose of this study is to learn more about the experiences of people with MS who are having a natalizumab infusion. Read More
Adults ages 18+.
Have multiple sclerosis.
Are enrolled in the New York State Multiple Sclerosis Consortium (NYSMSC),
Have taken natalizumab for the treatment of MS for at least six months.
This study enrolls current patients who have MS. The purpose of this study is to gain a better understanding of Severely Affected Patients with MS to lead to better early identification, treatment and care. Read More
Adults ages 30-75.
Must have been invited to participate by a provider.
We are looking for people with MS who have dysarthria and their caregivers for this research study. The purpose of this study is to find out is a software application can improve quality of life by making speech easier to understand. Read More
Adults ages 18-75.
Have been diagnosed with MS and moderate-severe dysarthria.
Have an iPhone or iPad.
This study enrolls people with advancing Relapsing Multiple Sclerosis (RMS). The purpose of the study is to see how safe and how well tolerated changing from one MS medication to siponimod (an investigational drug for MS) will be. Read More
Adults ages 18+.
Diagnosed with Relapsing Multiple Sclerosis (RMS).
We are looking for adults with MS who have participated in another study with our group for this study. The purpose of the study is to learn more about whether people with MS benefit from a phone app that helps teach conscientiousness. Read More
Adults ages 18+ with MS.
Must have been previously enrolled the "Multiple Sclerosis and Vocational Accommodations" study.
This study enrolls people with multiple sclerosis. The purpose of this study is to better understand if the Multiple Sclerosis Performance Test (MSPT) is a useful tool to collect data related to neurological function and quality of life in patients with MS or clinically isolated syndrome (CIS). Read More
Adults ages 18+ who have been diagnosed with multiple sclerosis (MS) or clinically isolated syndrome (CIS).